On Days 0, 6, and 27, blood (about 4 tablespoons) will be drawn to check the activity of the T-cells and their ability to attack the tumor. If you return for follow up this blood will also be drawn 6 weeks, 12 weeks, 3 months, 6 months, and 1 year after you receive the CXCR2 and NGFR T-cells.